SEK 109.2
(-1.09%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | - SEK | 0.0% |
2022 | - SEK | 0.0% |
2021 | - SEK | 0.0% |
2020 | - SEK | 0.0% |
2019 | - SEK | -100.0% |
2018 | 210 Million SEK | 20.69% |
2017 | 174 Million SEK | -18.31% |
2016 | 213 Million SEK | 21200.0% |
2015 | 1 Million SEK | 0.0% |
2014 | 1 Million SEK | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | - SEK | 0.0% |
2024 Q1 | - SEK | 0.0% |
2023 Q2 | - SEK | 0.0% |
2023 FY | - SEK | 0.0% |
2023 Q4 | - SEK | 0.0% |
2023 Q1 | - SEK | 0.0% |
2023 Q3 | - SEK | 0.0% |
2022 Q3 | -1.28 Billion SEK | -4.54% |
2022 Q4 | - SEK | 100.0% |
2022 Q2 | -1.23 Billion SEK | 0.88% |
2022 Q1 | -1.24 Billion SEK | 4.97% |
2022 FY | - SEK | 0.0% |
2021 Q2 | 380 Million SEK | 132.82% |
2021 Q3 | -1.17 Billion SEK | -409.21% |
2021 FY | - SEK | 0.0% |
2021 Q4 | -1.3 Billion SEK | -11.4% |
2021 Q1 | -1.15 Billion SEK | -7.42% |
2020 Q1 | 468 Million SEK | 143.41% |
2020 Q2 | -1.04 Billion SEK | -322.44% |
2020 Q3 | -1.01 Billion SEK | 2.31% |
2020 FY | - SEK | 0.0% |
2020 Q4 | -1.07 Billion SEK | -6.0% |
2019 Q4 | -1.07 Billion SEK | 6.75% |
2019 Q2 | -1.22 Billion SEK | -6.64% |
2019 Q1 | -1.14 Billion SEK | -469.35% |
2019 FY | - SEK | -100.0% |
2019 Q3 | -1.15 Billion SEK | 5.32% |
2018 Q1 | 294 Million SEK | 0.34% |
2018 FY | 210 Million SEK | 20.69% |
2018 Q4 | 310 Million SEK | 147.91% |
2018 Q3 | -647 Million SEK | -3.85% |
2018 Q2 | -623 Million SEK | -311.9% |
2017 FY | 174 Million SEK | -18.31% |
2017 Q1 | -563 Million SEK | -312.45% |
2017 Q2 | -569 Million SEK | -1.07% |
2017 Q3 | 351 Million SEK | 161.69% |
2017 Q4 | 293 Million SEK | -16.52% |
2016 Q1 | - SEK | 0.0% |
2016 FY | 213 Million SEK | 21200.0% |
2016 Q4 | 265 Million SEK | 0.0% |
2015 FY | 1 Million SEK | 0.0% |
2014 FY | 1 Million SEK | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Attendo AB (publ) | - SEK | NaN% |
Humana AB (publ) | - SEK | NaN% |
ProstaLund AB (publ) | 17 Million SEK | 100.0% |